Archive for December, 2009

Ethical and legal questions important in moving stem cell therapies to clinic

Author: Michael Rudnicki, 12/11/09

iPS cells give us an unprecedented opportunity to create patient- and disease-specific cells. Labs around the world have demonstrated that iPS cells can generate disease-specific cells for illnesses such as muscular dystrophy, Parkinson’s and type 1 diabetes, among many others. Generating these specific cell cultures is greatly advancing stem cell research by allowing researchers to…Read more